Mesa Laboratories (MLAB) Non-Current Deferred Tax Liability (2011 - 2026)

Mesa Laboratories has reported Non-Current Deferred Tax Liability for 15 years, with the latest figure at $21.8 million in Q4 2025.

• Quarterly Non-Current Deferred Tax Liability rose 8.18% year-over-year to $21.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.8 million (up 8.18% YoY) and the FY2025 annual result came in at $20.2 million, down 29.67% from the prior year.
• Non-Current Deferred Tax Liability climbed to $21.8 million in Q4 2025 per MLAB's latest filing, from $21.7 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $49.8 million in Q1 2023 and troughed at $10.8 million in Q2 2021.
• A 5-year average of $28.3 million and a median of $25.3 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2021 and 2022: Non-Current Deferred Tax Liability sank 65.37% in 2021, then jumped 245.14% in 2022.
• Over 5 years, Non-Current Deferred Tax Liability stood at $41.1 million in 2021, then declined by 10.18% to $36.9 million in 2022, then increased by 20.01% to $44.3 million in 2023, then sank by 54.49% to $20.2 million in 2024, then climbed by 8.18% to $21.8 million in 2025.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $21.8 million, $21.7 million, and $21.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.